EANS-News: SYGNIS Pharma AG / SYGNIS enters final stage with its Phase II...
——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Research &...
View ArticleEANS-News: SYGNIS Pharma AG / SYGNIS strengthens its KIBRA-Project: first...
——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Patents, Copyright...
View ArticleEANS-News: SYGNIS Pharma AG / SYGNIS further strengthens its patent position...
——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Patents, Copyright...
View ArticleRoche and Diagnostica Stago terminate partnership
Rotkreuz, Switzerland/Asnieres, France (ots) – Roche Professional Diagnostics and Diagnostica Stago announced today that the companies have decided to pursue separate paths in the business of...
View ArticleEANS-News: SYGNIS Pharma AG / SYGNIS announces last patient treated in its...
——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Research &...
View ArticleLEO Pharma Initiates Global Search for New Partners
Ballerup, Denmark (ots/PRNewswire) – LEO Pharma is now actively searching for new global or territorial partners to deliver promising new compounds for its dermatology-focused pipeline. Corporate VP...
View ArticleArecor Awarded Biomedical Catalyst Funding Towards £1.3 Million Project
Cambridge, England (ots/PRNewswire) – Cambridge biotech company Arecor has been awarded GBP785,000 from the government-backed Biomedical Catalyst Fund to accelerate the development of high...
View ArticleEANS-Adhoc: SYGNIS Pharma AG / SYGNIS announces Management Board changes
——————————————————————————– ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content...
View ArticleSYGNIS granted US patent for QUALIPHI®, the Next Generation DNA amplification...
Madrid/Heidelberg (ots) – SYGNIS granted US patent for QUALIPHI®, the Next Generation DNA amplification tool New patent opens SYGNIS and QUALIPHI® in a leading position in a EUR70 million global...
View ArticleSYGNIS licenses amplification buffer to QIAGEN
Madrid/Heidelberg (ots) - - Agreement follows a global licence agreement signed with QIAGEN in 2012. - First non-exclusive licence agreement for a new amplification buffer developed by Professor Salas...
View ArticleEANS-Adhoc: Valneva SE / Completion of Merger between Vivalis and Intercell...
——————————————————————————– ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement....
View ArticleDGAP-Adhoc: PAION SIGNS EXCLUSIVE OPTION AGREEMENT WITH HANA PHARM FOR...
PAION AG / Key word(s): Contract 02.07.2013 09:31 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP – a company of EQS Group AG. The issuer is solely responsible for...
View Article
